California to Register MIDAS Fumigant
Arysta LifeScience announced the California Department of Pesticide Regulation (CDPR) will register MIDAS for commercial use once regulations take effect to designate the fumigant as a restricted material and alternative to methyl bromide. California will be the 48th state to register MIDAS.

MIDAS is a broad-spectrum soil fumigant that controls soil-borne diseases, nematodes and weed seeds in ornamentals, strawberries, tomatoes, peppers, tree fruit, nuts, vines and turf.

MIDAS was first approved by the U.S. EPA in 2007 and has been applied to more than 16,000 acres in the United States with no safety incidents reported.

MIDAS is expected to be available in California in the first quarter of 2011.

More information is available at

Gowan Acquires Rights To M-Pede Insecticide/Fungicide, Scythe Herbicide
Gowan Co., LLC
has reached an agreement with Dow AgroSciences LLC to acquire the rights to M-Pede insecticide/fungicide and Scythe herbicide. M-Pede is an OMRI-certified insecticide/fungicide that controls aphids, thrips and mites on a variety of crops, including vegetables, grapes, tree fruits, tree nuts, cotton and ornamentals. Scythe is a nonselective herbicide used for controlling a broad spectrum of weeds. Under this agreement, Gowan and its subsidiaries began selling M-Pede and Scythe effective November 10, 2010. Financial terms of the agreement were not disclosed.

Learn more at

Valent BioSciences Achieves ISO 9001:2008 Registration for U.S. Operations
Valent BioSciences Corp. has achieved ISO 9001:2008 registration of its U.S. operations. Valent BioSciences serves customers in more than 90 countries. Its products include DiPel, XenTari, ProGibb, Promalin, ReTain and VectoBac.

The approval for registration follows the recommendation of the official auditing team, which conducted an extensive audit of Valent BioSciences’ Quality Management System.

Valent BioSciences received its ISO 9001:2008 registration from Perry Johnson Registrars, Inc., a nationally accredited registrar that performs assessments of quality management systems against requirements of national and international standards for quality.

For more information, call 800-323-9597 or visit .

Monsanto Adds Ipsen to Board of Directors
Monsanto Co. announced the appointment of Laura K. Ipsen to the company’s board of directors. Ipsen is currently the senior vice president and general manager, Connected Energy Industries, for Cisco in San Jose, Calif. In addition, she is the co-chair of Cisco’s EcoBoard, which defines and drives the company’s global environmental strategy, including how to use information technology to achieve a positive impact on the environment and climate change.

Prior to Cisco, she worked in government affairs and international trade for Hitachi Data Systems, Acer Corp. and PricewaterhouseCoopers LLP.

Ipsen’s appointment is effective immediately, and she will stand for election to the board at the 2011 annual meeting of shareowners. Ipsen will serve on the Science and Technology Committee and the Sustainability and Corporate Responsibility Committee.

The addition of Ipsen to Monsanto’s board brings the number of directors to 12, with 11 independent directors.

Additional information can be found at

EPA Solicits Comments on Petition Regarding Antimicrobial Pesticide Triclosan
The United States Environmental Protection Agency (EPA) is publishing in the Federal Register a petition from Beyond Pesticides and Food and Water Watch requesting a ban on the antimicrobial pesticide triclosan. Comments will be accepted for 60 days.

Triclosan is an antimicrobial active ingredient with uses regulated by both EPA and the Food and Drug Administration (FDA). Triclosan is contained in a variety of bacteriostats, fungistats, mildewstats and deodorizer products. There are currently 20 antimicrobial registrations that EPA regulates under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA).

Triclosan also has consumer uses regulated by FDA under the Federal Food, Drug, and Cosmetic Act (FFDCA), which include over-the-counter products such as antimicrobial hand soaps and toothpaste. The same organizations also filed a petition with FDA. FDA will respond separately to the petitioners on the issues under the purview of their regulatory authority. EPA and FDA intend to collaborate and share information throughout the public comment and petition response process as well as FDA’s ongoing effort to complete a topical antimicrobial over-the-counter (OTC) drug monograph, under which some of these products are regulated.

EPA completed a Reregistration Eligibility Decision (RED) for triclosan in 2008. The RED estimated the potential for exposure to triclosan from the use of consumer products containing the chemical. The agency concluded that total exposure to triclosan from all sources does not present risks of concern. However, because of the amount of research being planned and currently in progress, the agency recently decided to undertake another comprehensive review of triclosan (under the Registration Review Program) beginning in 2013, ten years earlier than originally planned.

Comments on this Federal Register notice will be accepted until February 7, 2011, and may be submitted at in Docket ID # EPA-HQ-OPP-2010-0548.

Information about EPA’s RED assessment of triclosan can be found at